March 06, 2015 10:08 AM ET

Biotechnology

Company Overview of Celladon Corporation

Company Overview

Celladon Corporation, a clinical-stage biotechnology company, focuses on developing treatments for heart failure, diabetes, and neurodegenerative diseases. The company’s lead product candidate includes MYDICAR that uses genetic enzyme replacement therapy to correct the Sarco/endoplasmic reticulum Ca 2+ -ATPase 2a enzyme deficiency in heart failure patients that results in inadequate pumping of the heart. Its MYDICAR product is developed to treat patients with systolic heart failure, diastolic heart failure, and advanced heart failure, as well as to treat pulmonary arterial hypertension and arteriovenous fistula maturation failure. The company was founded in 2000 and is headquartered in San D...

12760 High Bluff Drive

Suite 240

San Diego, CA 92130

United States

Founded in 2000

26 Employees

Phone:

858-366-4288

Fax:

858-964-0974

Key Executives for Celladon Corporation

Chief Executive Officer and Director
Age: 58
Total Annual Compensation: $417.5K
Principal Financial & Accounting Officer and Vice President of Finance & Administration
Age: 53
Total Annual Compensation: $216.3K
Vice President of Corporate Development & Investor Relations
Age: 43
Total Annual Compensation: $190.4K
Vice President of Clinical Operations
Age: 52
Total Annual Compensation: $216.3K
Compensation as of Fiscal Year 2013.

Celladon Corporation Key Developments

Celladon Corporation Conducts Initial Scale Up of Manufacturing Process for MYDICAR to Commercial Scale

Celladon Corporation announced that it has conducted initial scale up of its viral manufacturing process for MYDICAR (AAV1/SERCA2a) to commercial scale. The scale up of primary production and downstream processing development to 2,000 liters was undertaken together with Lonza, in its facility in Houston, Texas.

Celladon Corporation(NasdaqGM:CLDN) added to NASDAQ Biotechnology Index

Celladon Corporation will be added to the NASDAQ Biotechnology Index.

Celladon Corporation Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 08:20 AM

Celladon Corporation Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 08:20 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Kristina Zsebo, CEO.

Similar Private Companies By Industry

Company Name Region
SEDLine, Inc. United States
Bristol-Myers Squibb & Gilead Sciences, LLC United States
Progression Therapeutics, Inc. United States
Plasmonix, Inc. United States
Arkion Life Sciences, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Celladon Corporation, please visit www.celladon.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.